Stage IIIB Breast Cancer Active Not Recruiting Phase 2 Trials for Capecitabine (DB01101)

DBCOND0028549 (Stage IIIB Breast Cancer)Active Not Recruiting2 IdentifierTitlePurposeDrugs
NCT00684983Capecitabine and Lapatinib Ditosylate With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB-IV Breast CancerTreatment
NCT03044730Pembrolizumab and Capecitabine in Treating Patients With Locally Advanced or Metastatic Triple Negative or Hormone-Refractory Breast Cancer That Cannot Be Removed by SurgeryTreatment